NEW YORK (Reuters Health) – Patients with acute migraine who find sumatriptan ineffective may have a better response to rizatriptan, according to a study reported in Cephalalgia online…
NEW YORK (Reuters Health) – Augmenting antipsychotic treatment with a biologically active natural product, L-theanine, improves symptoms in patients with schizophrenia or schizoaffective disorder, Israeli investigators have shown…
NEW YORK (Reuters Health) – The IL-6 receptor-blocking monoclonal antibody tocilizumab inhibits joint damage in patients with rheumatoid arthritis that is not adequately controlled with methotrexate, according to…
NEW YORK (Reuters Health) – Urologists from China report that the alpha-adrenergic receptor antagonist tamsulosin is a good first-line drug for outpatient medical expulsive therapy (MET) in patients…
NEW YORK (Reuters Health) – Ultrasound-guided high-intensity focused ultrasound (HIFU) ablation and the levonorgestrel intrauterine system (LNG-IUS) offer less invasive options for treating women with symptomatic adenomyosis, according…
NEW YORK (Reuters Health) – A molecular complex of aspirin and phosphatidylcholine called PL2200 seems to protect against acute gastroduodenal erosion and ulceration in older adults at risk…
NEW YORK (Reuters Health) – In adolescents and adults with active eosinophilic esophagitis (EoE), a 15-day induction course of nebulized budesonide is sufficient to induce histologic remission and…
NEW YORK (Reuters Health) – Vaccinating pregnant women against influenza is a highly effective way of keeping their infants from being hospitalized with influenza in the first six…
NEW YORK (Reuters Health) – In 2009, people given the seasonal trivalent influenza vaccine were at higher risk of infection with the pandemic H1N1 strain than those given…
NEW YORK (Reuters Health) – Cure rates are similar when patients hospitalized with community-acquired pneumonia are treated with ceftaroline or ceftriaxone — but ceftaroline may have the edge,…